Skip to main content
. 2021 Nov 5;3(12):699–706. doi: 10.1253/circrep.CR-21-0129

Table 3.

Clinical Characteristics of 91 Patients With De Novo Calcified Nodules

  Overall Restenosis
No Yes P value
No. patients 91 62 29  
Age (years) 74.1±9.7 75.5±9.6 71.1±9.5 0.044
Male sex 63 (69.2) 39 (62.9) 24 (82.8) 0.087
Hypertension 78 (85.7) 53 (85.5) 25 (86.2) 1
Diabetes 42 (46.2) 23 (37.1) 19 (65.5) 0.014
Dyslipidemia 64 (70.3) 47 (75.8) 17 (58.6) 0.139
Hemodialysis 23 (25.3) 12 (19.4) 11 (37.9) 0.072
Prior PCI 38 (41.8) 22 (35.5) 16 (55.2) 0.11
Prior CABG 4 (4.4) 4 (6.5) 0 (0.0) 0.302
Lesion location (RCA/LMT-LAD/LCX) 53/34/4 31/28/3 22/6/1 0.048
Multivessel disease 72 (79.1) 49 (79.0) 23 (79.3) 1
ACS 49 (53.8) 33 (53.2) 16 (55.2) 1
Lesion characteristics
 ≥99% stenosis 38 (41.8) 21 (33.9) 17 (58.6) 0.039
 Tortuous 53 (58.2) 31 (50.0) 22 (75.9) 0.024
 Mild/moderate/severe calcification (n) 8/23/60 7/18/37 1/5/23 0.217
Treatment strategy
 Rotational atherectomy 52 (57.1) 41 (66.1) 11 (37.9) 0.014
 Scoring balloon 37 (40.7) 25 (40.3) 12 (41.4) 1
 Drug-eluting stent 73 (80.2) 47 (75.8) 26 (89.7) 0.162
 Drug-coated balloon 12 (13.2) 10 (16.1) 2 (6.9) 0.325
 ELCA 2 (2.2) 1 (1.6) 1 (3.4) 0.538

Unless indicated otherwise, data are given as the mean±SD or n (%). ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; ELCA, excimer laser coronary angioplasty; LAD, left anterior descending artery; LCX, left circumflex artery; LMT, left main trunk; PCI, percutaneous coronary intervention; RCA, right coronary artery.